Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Effect of oxandrolone and timing of pubertal induction on final height in Turner syndrome: final analysis of the UK randomised placebo-controlled trial.

Gault EJ, Cole TJ, Casey S, Hindmarsh PC, Betts P, Dunger DB, Donaldson MDC.

Arch Dis Child. 2019 Dec 20. pii: archdischild-2019-317695. doi: 10.1136/archdischild-2019-317695. [Epub ahead of print]

PMID:
31862699
2.

Testosterone therapy and cancer risk.

Eisenberg ML, Li S, Betts P, Herder D, Lamb DJ, Lipshultz LI.

BJU Int. 2015 Feb;115(2):317-21. doi: 10.1111/bju.12756. Epub 2014 Oct 20.

3.

Dynamics of continental accretion.

Moresi L, Betts PG, Miller MS, Cayley RA.

Nature. 2014 Apr 10;508(7495):245-8. doi: 10.1038/nature13033. Epub 2014 Mar 23.

PMID:
24670638
4.

Increased cancer risk and azoospermia.

Eisenberg ML, Betts P, Herder D, Lamb DJ, Lipshultz LI.

Fertil Steril. 2013 Sep;100(3):e12. doi: 10.1016/j.fertnstert.2013.06.025. Epub 2013 Jul 11. No abstract available.

PMID:
23850299
5.

Increased risk of cancer among azoospermic men.

Eisenberg ML, Betts P, Herder D, Lamb DJ, Lipshultz LI.

Fertil Steril. 2013 Sep;100(3):681-5. doi: 10.1016/j.fertnstert.2013.05.022. Epub 2013 Jun 21.

6.
7.

Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial.

Gault EJ, Perry RJ, Cole TJ, Casey S, Paterson WF, Hindmarsh PC, Betts P, Dunger DB, Donaldson MD; British Society for Paediatric Endocrinology and Diabetes.

BMJ. 2011 Apr 14;342:d1980. doi: 10.1136/bmj.d1980.

8.

Management of children and adolescents with diabetes requiring surgery.

Betts P, Brink S, Silink M, Swift PG, Wolfsdorf J, Hanas R.

Pediatr Diabetes. 2009 Sep;10 Suppl 12:169-74. doi: 10.1111/j.1399-5448.2009.00579.x. Review. No abstract available.

PMID:
19754627
9.

Torque removal force for osseointegrated implants--two experimental studies.

Lownie JF, Betts PA, Bryant RS, Cleaton-Jones P.

S Afr J Surg. 2008 Feb;46(1):18-20.

PMID:
18468418
11.

Management of children with diabetes requiring surgery.

Betts P, Brink SJ, Swift PG, Silink M, Wolfsdorf J, Hanas R; ISPAD.

Pediatr Diabetes. 2007 Aug;8(4):242-7. No abstract available.

PMID:
17659068
12.

The importance of re-evaluation, re-investigation and follow-up of adrenal insufficiency.

Russo C, Davis EJ, Betts PR, Davies JH.

Arch Dis Child Educ Pract Ed. 2007 Aug;92(4):ep109-13. No abstract available.

PMID:
17644664
13.

Strategic planning: is a turnaround in your hospital's future?

Betts PJ.

Trustee. 2007 Mar;60(3):34-6. No abstract available.

PMID:
17484259
14.

Galactosaemia presenting as bedside hyperglycaemia.

Hyde P, Betts P.

J Paediatr Child Health. 2006 Oct;42(10):659. No abstract available.

PMID:
16972979
15.

Redesigning the revenue cycle. Comprehensive revenue cycle reengineering can dramatically improve operating margins.

Betts PJ, Hanson TH.

Healthc Exec. 2005 Jul-Aug;20(4):44-5. No abstract available.

PMID:
16033014
16.
17.

Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia.

Storr HL, Mitchell H, Swords FM, Main KM, Hindmarsh PC, Betts PR, Shaw NJ, Johnston DI, Clark AJ, Reznek RH, Grossman AB, Savage MO.

Clin Endocrinol (Oxf). 2004 Nov;61(5):553-9.

PMID:
15521956
18.

An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission.

Shield JP, Temple IK, Sabin M, Mackay D, Robinson DO, Betts PR, Carson DJ, Cavé H, Chevenne D, Polak M.

Arch Dis Child Fetal Neonatal Ed. 2004 Jul;89(4):F341-3.

19.
20.

Personality functioning: the influence of stature.

Ulph F, Betts P, Mulligan J, Stratford RJ.

Arch Dis Child. 2004 Jan;89(1):17-21.

21.

Doctor, who will be looking after my child's diabetes?

Betts PR, Swift PG.

Arch Dis Child. 2003 Jan;88(1):6-7. No abstract available.

22.

Diabetes care in childhood and adolescence.

Betts PR, Jefferson IG, Swift PG.

Diabet Med. 2002 Jul;19 Suppl 4:61-5.

PMID:
12121340
23.
24.

Pancreatic exocrine insufficiency and type 1 diabetes mellitus.

Canaway S, Phillips I, Betts P.

Br J Nurs. 2000 Oct 12-25;9(18):2030-2.

PMID:
11868210
25.

Type 2 diabetes in obese white children.

Drake AJ, Smith A, Betts PR, Crowne EC, Shield JP.

Arch Dis Child. 2002 Mar;86(3):207-8.

26.

Hormones and handedness.

Mulligan J, Stratford RJ, Bailey BJ, McCaughey ES, Betts PR.

Horm Res. 2001;56(1-2):51-7.

PMID:
11815728
27.

Longitudinal study of urinary albumin excretion in young diabetic patients--Wessex Diabetic Nephropathy Project.

Twyman S, Rowe D, Mansell P, Schapira D, Betts P, Leatherdale B; Wessex Diabetic Nephropathy Project.

Diabet Med. 2001 May;18(5):402-8.

PMID:
11472452
28.

Short stature in Noonan syndrome: response to growth hormone therapy.

Kirk JM, Betts PR, Butler GE, Donaldson MD, Dunger DB, Johnston DI, Kelnar CJ, Price DA, Wilton P, Group tU.

Arch Dis Child. 2001 May;84(5):440-3.

29.

A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis.

Johnston DI, Betts P, Dunger D, Barnes N, Swift PG, Buckler JM, Butler GE.

Arch Dis Child. 2001 Jan;84(1):76-81.

30.

Pubertal growth of the short normal girl.

Mulligan J, Bailey BJ, Voss LD, Betts PR.

Horm Res. 1999;52(6):261-8.

PMID:
10965204
31.
32.

An assessment of paediatric diabetes care in three centres in Russia and in Southampton, UK. The Paediatric Teams in Moscow, Tula, Tambov, Southampton.

Betts PR, Logatchov M, Volkov I, Murphy H, Dombrowskaya N, Borzikh S, Ivanova I, Twyman S, Vartan J.

Diabet Med. 1999 Sep;16(9):772-8.

PMID:
10510955
33.

A decade of growth hormone treatment in girls with Turner syndrome in the UK. UK KIGS Executive Group.

Betts PR, Butler GE, Donaldson MD, Dunger DB, Johnston DI, Kelnar CJ, Kirk J, Price DA, Wilton P.

Arch Dis Child. 1999 Mar;80(3):221-5.

34.

Strategic planning. Trick or treat?

Betts PJ.

Trustee. 1998 Jan;51(1):24-5. No abstract available.

PMID:
10176697
35.

Growth monitoring: testing the new guidelines.

Mulligan J, Voss LD, McCaughey ES, Bailey BJ, Betts PR.

Arch Dis Child. 1998 Oct;79(4):318-22.

36.

Randomised trial of growth hormone in short normal girls.

McCaughey ES, Mulligan J, Voss LD, Betts PR.

Lancet. 1998 Mar 28;351(9107):940-4.

PMID:
9734940
37.

Mucosal and systemic antibody responses to a C4/V3 construct following DNA vaccination of rabbits via the Peyer's patch.

Winchell JM, Routray S, Betts PW, Van Kruiningen HJ, Silbart LK.

J Infect Dis. 1998 Sep;178(3):850-3.

PMID:
9728557
38.

Short stature at school entry--an index of social deprivation? (The Wessex Growth Study).

Voss LD, Mulligan J, Betts PR.

Child Care Health Dev. 1998 Mar;24(2):145-56.

PMID:
9544443
39.

Early infection and subsequent insulin dependent diabetes.

Gibbon C, Smith T, Egger P, Betts P, Phillips D.

Arch Dis Child. 1997 Nov;77(5):384-5.

40.

Are short normal children at a disadvantage? The Wessex growth study.

Downie AB, Mulligan J, Stratford RJ, Betts PR, Voss LD.

BMJ. 1997 Jan 11;314(7074):97-100.

41.

The care of young people with diabetes.

Betts P, Buckley M, Davies R, McEvilly E, Swift P.

Diabet Med. 1996 Sep;13(9 Suppl 4):S54-9. Review. No abstract available.

PMID:
8894456
42.

Psychological response to growth hormone treatment in short normal children.

Downie AB, Mulligan J, McCaughey ES, Stratford RJ, Betts PR, Voss LD.

Arch Dis Child. 1996 Jul;75(1):32-5.

43.

Cardiac effects of growth hormone in short normal children.

Daubeney PE, Betts PR, Webber SA.

Arch Dis Child. 1995 Sep;73(3):278. No abstract available.

44.

Reliability of infant length measurement.

Doull IJ, McCaughey ES, Bailey BJ, Betts PR.

Arch Dis Child. 1995 Jun;72(6):520-1.

45.

Cardiac effects of growth hormone in short normal children: results after four years of treatment.

Daubeney PE, McCaughey ES, Chase C, Walker JM, Slavik Z, Betts PR, Webber SA.

Arch Dis Child. 1995 Apr;72(4):337-9. Erratum in: Arch Dis Child. 1995 Sep;73(3):278.

46.

An imprinted gene(s) for diabetes?

Temple IK, James RS, Crolla JA, Sitch FL, Jacobs PA, Howell WM, Betts P, Baum JD, Shield JP.

Nat Genet. 1995 Feb;9(2):110-2. No abstract available.

PMID:
7719335
47.

Biosynthetic human growth hormone treatment in the UK: an audit of current practice. Kabi Pharmacia International Growth Study.

Price DA, Johnston DI, Betts PR, Buckler JM, Donaldson MD.

Arch Dis Child. 1994 Sep;71(3):266-71. No abstract available.

48.

Growth and metabolic consequences of growth hormone treatment in prepubertal short normal children.

McCaughey ES, Mulligan J, Voss LD, Betts PR.

Arch Dis Child. 1994 Sep;71(3):201-6.

49.

A cryptic miniplasmid from the hyperthermophilic bacterium Thermotoga sp. strain RQ7.

Harriott OT, Huber R, Stetter KO, Betts PW, Noll KM.

J Bacteriol. 1994 May;176(9):2759-62.

50.

Screening for growth disorders.

Voss LD, Betts PR.

J Med Screen. 1994 Apr;1(2):136. No abstract available.

PMID:
8790503

Supplemental Content

Support Center